Co-prescribing of proton pump inhibitors among chronic users of NSAIDS in the UK

Rheumatology

Volumn 47, Issue 4, 2008, Pages 458-463

  Suh, D C ^a   Hunsche, E ^b   Shin, H C ^a   Mavros, Panagiotis ^b  

^a RUTGERS UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Drug utilization; NSAIDs; PPIs; Retrospective observational study

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG SAFETY; DRUG UTILIZATION; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; STOMACH PROTECTION; UNITED KINGDOM; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG COMBINATION; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 43049175244     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem375     Document Type: Article

References (35)

1. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001;120:594-606.
2. IMS Health Disease Analyzer-Mediplus as assessed by Merck Sharp & Dohme Limited. Mar 2005.
3. Fricker J, for Mundipharma International Ltd. Pain in Europe - a report. On Pain in Europe website. http://www.painineurope.com/user_site/ index.cfm?item_id=4405413. (updated 5 October 2004; 6 January 2006, date last accessed).
4. MacDonald TM. Epidemiology and pharmacoeconomic implications of non-steroidal anti-inflammatory drug-associated gastrointestinal toxicity. Rheumatology 2000;39(Suppl 2):13-20.
5. Hernández-Díaz S, Garcia Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: An overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000;160:2093-9.
6. National Institute for Clinical Excellence, National Health Service. Management of dyspepsia in adults in primary care. Clinical Guideline 17. On NICE website. http://www.nice.org.uk/pdf/CG017NICEguideline.pdf. (updated 2004 August; 14 June 2005, date last accessed).
7. Jordan KM, Arden NK, Doherty M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55.
8. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46:328-46.
9. Tannenbaum H, Peloso PM, Russell AS, Marlow B. An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The second Canadian consensus conference. Can J Clin Pharmacol 2000; 7(Suppl A):4A-16A.
10. Hawkey C, Talley NJ, Yeomans ND et al. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol 2005;100:1028-36.
11. Graham DY, Agrawal NM, Campbell DR et al. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: Results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 2002;162:169-75.
12. Lai KC, Lam SK, Chu KM et al. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users-a randomized trial. Aliment Pharmacol Ther 2003;18:829-36.
13. Chan FK, Chung SC, Suen BY et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.
14. Laine L. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms. Rev Gastroenterol Disord 2003;3(Suppl 4):S30-9.
15. Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: Increasing frequency of haemorrhage among older subjects. Gut 2002;50:460-4.
16. Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology 2003;42(Suppl 3):iIi23-31.
17. Smalley W, Stein CM, Arbogast PG, Eisen G, Ray WA, Griffin M. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum 2002;46:2195-200.
18. Rahme E, Marentette MA, Kong SX, LeLorier J. Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population. Arthritis Rheum 2002;47:595-602.
19. Sebaldt RJ, Petrie A, Goldsmith CH, Marentette MA. Appropriateness of NSAID and coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: Results from the CANOAR study. Am J Manag Care 2004; 10:742-50.
20. Sturkenboom MC, Burke TA, Tangelder MJ, Dieleman JP, Walton S, Goldstein JL. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2003;18: 1137-47.
21. Goldstein JL. Challenges in managing NSAID-associated gastrointestinal tract injury. Digestion 2004;69(Suppl 1):25-33.
22. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Pub Health Med 1999;21:299-304.
23. Lawrenson RA, Coles G, Walton K, Farmer RDT. Characteristics of practices contributing to the MediPlus database and the implications for its use in epidemiological research. J Inform Prim Care 1998;1:14-8.
24. Langman M, Kahler KH, Kong SX et al. Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: A retrospective cohort study of a general practitioners database in the United Kingdom. Pharmacoepidemiol Drug Saf 2001;10:517-24.
25. Hunt RH, Barkun AN, Baron D et al. Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of gastroprotective agents. Can J Gastroenterol 2002;16:231-40.
26. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999;340:1888-99.
27. Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998;104:23S-9S.
28. Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D. Gastroprotective therapy and risk of gastrointestinal ulcers: Risk reduction by COX-2 therapy. J Rheumatol 2002;29:467-73.
29. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: Switzerland, 2003.
30. Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Statist 1983;1:115-26.
31. Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econ 2001;20:461-94.
32. Rostom A, Dube C, Wells G et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 2004;4(CD002296):1-111.
33. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 1996;156:1530-6.
34. Hungin AP, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999;49:463-4.
35. Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: Systematic review. Br Med J 2004;329: 948-57.